Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-26
2011-04-26
Chung, Susannah (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S215000, C548S262200
Reexamination Certificate
active
07932280
ABSTRACT:
Triazole derivatives of structural formula I are selective inhibitors of the 11β-hydroxysteroid dehydrogenase-1. The compounds are useful for the treatment of diabetes, such as noninsulin-dependent diabetes (NIDDM), hyperglycemia, obesity, insulin resistance, dyslipidemia, hyperlipidemia, hypertension, Metabolic Syndrome, and other symptoms associated with NIDDM.
REFERENCES:
patent: 6849636 (2005-02-01), Waddell et al.
patent: 2005/0070720 (2005-03-01), Balkovec et al.
Gu Xin
Kevin Nancy J.
Waddell Sherman T.
Chung Susannah
Fitch Catherine D.
Merck Sharp & Dohme Corp.
Parr Richard S.
Struse Heidi M.
LandOfFree
Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Triazole derivatives as inhibitors of 11-beta-hydroxysteroid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Triazole derivatives as inhibitors of 11-beta-hydroxysteroid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2629678